China · Who invested in Tot Biopharm?
Tot Biopharm's investors include Cathay Capital, Chengwei Capital, China Universal/ Center Laboratories Group, Vivo and Yuanta Financial Holdings.
China · Series B startup
Who invested in Tot Biopharm
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$102Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $102MAug 2018
- Investors
- 5
The rounds
- Aug 2018Series B$102M
Cathay Capital
Chengwei Capital- China Universal/ Center Laboratories Group
- Vivo
- Yuanta Financial Holdings
Reported by FinSMEs
Everyone who backed them
China Universal/ Center Laboratories Groupno record of our own yet1round
Vivono record of our own yet1round
Yuanta Financial Holdingsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Tot Biopharm
How much has Tot Biopharm raised?
Tot Biopharm has raised $102M across 1 round since 2018.
When did Tot Biopharm last raise?
Tot Biopharm's most recent round was a Series B of $102M in Aug 2018.
What was Tot Biopharm's biggest round?
Its most recent round, $102M in Aug 2018, is also its largest on record.
Who backed Tot Biopharm first?
Tot Biopharm's first round on record, in Aug 2018, was backed by Cathay Capital, Chengwei Capital and China Universal/ Center Laboratories Group and 2 others.
What stage is Tot Biopharm at?
Tot Biopharm's latest named round is a Series B, in Aug 2018.
Where is Tot Biopharm based?
Tot Biopharm is based in China.
Companies like Tot Biopharm
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.